🇺🇸 FDA
Patent

US 12186285

Compositions and methods of treatment for tinea pedis

granted A61KA61K31/137A61K31/17

Quick answer

US patent 12186285 (Compositions and methods of treatment for tinea pedis) held by Compass Therapeutics LLC expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/137, A61K31/17, A61P, A61P31/10